Bextra Malpractice Claim

Bextra Malpractice Claim

The number three in Cox-2 inhibitor is Bextra. Bextra is used by arthritis patients as an anti-inflammatory and pain killer. Bextra helps by minimizing matter in the body that causes inflammation, pain, and fever, and is used to reduce pain, inflammation, and stiffness caused by osteoarthritis and adult rheumatoid arthritis and in also painful menstruation.

FDA ceased the marketing of Bextra in April 2005 as it had high risk of cardiovascular problems, strokes and severe skin reactions. The warning label warns the following about potential severe skin reactions, even Steven Johnson syndrome and also epidermal necrolysis. These in few cases have resulted to death. Side affects of Bextra is abdominal pain, discomfort, (Bloody, black, or tarry) stools, Bloody vomit, abnormal fatigue, yellowing of the skin or eyes, extraordinary bruising or bleeding. People having asthma and allergic reactions to similar drugs should avoid Bextra.

FDA had total of 87 cases of severe skin reaction related to Bextra in November 2004 and 0 out of 87 suffered with an allergy sulfa and 4 deaths. A study with Bextra on 1500 Bypass surgery patients showed high cardiovascular problem, heart attack, stroke, blood clots in leg and also lungs. The company presented a report on November 5, 2004 and asserted the risk of oral Bextra following Bypass surgery. FDA considers that these findings should be given to Doctors and patients and contradicts the usage of Bextra post CABG surgery. In case of any complications, the Bextra lawyers in the local state can be contacted for further queries and help.